We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Alcohol Exposed Pregnancy Risk: EARLY Randomized Controlled Trial (EARLY RCT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01446653
First Posted: October 5, 2011
Last Update Posted: October 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by (Responsible Party):
Karen Ingersoll, University of Virginia
  Purpose
The EARLY Randomized Controlled Trial (RCT) will test the finalized EARLY preventive intervention against one comparison and one control condition. Because prevention of Alcohol-exposed pregnancy (AEP) will be achieved whether woman change drinking OR contraception, the primary endpoints will be rates of risky drinking and ineffective contraception at six-month follow-up, in addition to dichotomously defined "successful outcome" that will be observed whenever a woman has sufficiently altered one or both of the behaviors that placed her at risk of Alcohol-Exposed Pregnancy (AEP). The goal is to identify a transferable intervention that effectively reduces behaviors that put women at risk for AEP and alcohol-related birth defects including FASD.

Condition Intervention
Alcohol Exposed Pregnancy Behavioral: Motivational Interviewing plus feedback Behavioral: Video Behavioral: Informational Brochure

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Reducing Alcohol Exposed Pregnancy Risk

Resource links provided by NLM:


Further study details as provided by Karen Ingersoll, University of Virginia:

Primary Outcome Measures:
  • Drinks per drinking day [ Time Frame: 6 months ]
  • Rate of effective contraception [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • Alcohol Exposed Pregnancy risk [ Time Frame: 6 months ]
    Risk for AEP is defined as the proportion of women who no longer meet the entry criteria for the trial based on her use of alcohol and unprotected intercourse, measured via the TLFB. Specifically, this means that the woman is 1) no longer at risk for pregnancy due to perfect contraception or abstinence; and/or 2) is drinking at or below recommended levels (<8drinks per week with no binges).


Enrollment: 232
Study Start Date: February 2007
Study Completion Date: September 2011
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: EARLY
Motivational Interviewing plus feedback counseling with information via video and brochures
Behavioral: Motivational Interviewing plus feedback
Provides an MI + feedback intervention supplemented with video and brochures-based information
Active Comparator: Video Information
Providing FASD information via documentary video clips
Behavioral: Video
Video arm will provide information via documentary video
Active Comparator: Informational Brochure
Participants will receive informational brochures on contraception, women and drinking, and cutting down your drinking.
Behavioral: Informational Brochure
Informational Brochures are given to participants following baseline assessment.

  Hide Detailed Description

Detailed Description:

Drinking women are at risk for alcohol-exposed pregnancy (AEP) if they use contraception ineffectively. Binge drinking among women of childbearing age has increased, and risky frequent drinking has remained stable in this group of women. Although many women stop or reduce their drinking once they realize they are pregnant, pregnancy recognition does not occur until the 4th to 6th week of gestation for most women. Serious harm can occur to the fetus, especially between weeks 3 and 10 of gestation, if women drink during this period. Additionally, increasing numbers of women are drinking during pregnancy, despite public health warnings and scientific proof that alcohol is a teratogen. Although many women are aware of Fetal Alcohol Syndrome (FAS), few are aware that even low levels of alcohol exposure could lead to alcohol-related neurobehavioral disorders and alcohol-related birth defects (ARND, ARBD), now known as Fetal Alcohol Spectrum Disorders (FASD). Intervening before conception with women who are at risk for AEP could eliminate some cases of FASD. Women at risk are problem drinkers who fail to use contraception effectively, and those with ineffective contraception who sometimes drink at risk levels. Intervention could focus on postponing pregnancy among problem drinkers, or reducing drinking among women who forgo pregnancy prevention, or both.

Motivational interviewing focusing on the dual behaviors that compose risk for AEP is a promising approach. A five session, dual-focused motivational interviewing plus contraception counseling intervention was effective for women at risk for AEP who were not seeking treatment. Unfortunately, even though such interventions may prove effective, they are unlikely to be adopted in community settings due to their length and cost. What is needed is a less costly, transportable brief intervention that uses the effective components of these longer interventions, but delivers them in a condensed format. A briefer intervention could be used with women awaiting services or added to existing therapeutic services, and thus could have a larger public health impact on reducing the risk of AEP for women drawn from diverse settings. A single-session intervention, Project Balance, has shown evidence of efficacy with college women, but will require adaptation for less educated community-based women with more severe drinking problems or less contraception use. The next step needed to advance this field is to develop and test a less time-intensive intervention that builds on effective and theory-based interventions, and to test that intervention in women drawn from higher risk settings.

The purpose of this Stage 1b project is to develop and test the efficacy of a brief, theory-based, behavioral intervention among a high-risk community sample of fertile women who are at particularly high risk for an alcohol-exposed pregnancy (AEP). Because prevention of AEP will be achieved whether woman change drinking OR contraception, the primary endpoints will be rates of risky drinking and ineffective contraception at six-month follow-up, in addition to dichotomously defined "successful outcome" that will be observed whenever a woman has sufficiently altered one or both of the behaviors that placed her at risk of AEP. The goal is to identify a transferable intervention that effectively reduces behaviors that put women at risk for AEP and alcohol-related birth defects including FASD. The specific aims are to:

  1. Develop the "Exploring Alcohol and Contraception Risks that Limit You" (EARLY) intervention, refine training methods and materials, and train therapists to deliver the intervention accurately.
  2. Develop measures of the internal validity and fidelity of the intervention, and establish their psychometric properties.
  3. Test the efficacy of the EARLY intervention against a minimal intervention condition that controls for the effects of assessment, time, and attention. Efficacy to retain participants, reduce drinking, and increase contraception will be tested in a pilot randomized trial of women drawn from the target populations: settings serving problem drinkers (outpatient drug and alcohol treatment settings) or women with ineffective contraceptive habits (STD and public health clinics)
  4. Develop materials needed for a Stage 2 efficacy trial, including evidence of the feasibility and promise of the EARLY intervention, treatment manuals, therapist training materials, and a final instrumentation package.
  5. Examine the role of variables other than group assignment (alcohol problem severity, psychiatric co-morbidity, drug use/severity, trans-theoretical model variables (readiness, stages, and processes of change, self efficacy, and therapeutic alliance) to mediate or moderate response, and examine secondary outcomes of the intervention, such as changes in readiness.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 44 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • ages 18-44
  • fertile
  • can provide informed consent
  • had vaginal intercourse with a man in the past 3 months
  • uses ineffective or no contraception
  • speaks and reads English
  • reports drinking more than seven standard drinks per week on average or more than one binge drinking episode (more than 3 standard drinks on one occasion) during the past 3 months
  • if opioid dependent with recent use, is enrolled in opiate agonist treatment
  • planning to remain available for the follow-up period

Exclusion Criteria:

  • pregnancy
  • cognitive disorders including mental retardation, dementia, or active -psychosis that could impair ability to understand the intervention material or give informed consent
  • current Major Depressive Disorder that could diminish responsiveness to interventions focused on promoting change
  • currently opioid dependent with active use and not engaged in opiate agonist treatment
  • concurrently participating in another behavioral intervention study during the study period targeting drinking or contraception efficacy that could interfere with or augment the intervention in the EARLY project.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01446653


Locations
United States, Virginia
UVA CARE
Charlottesville, Virginia, United States, 22911
UVA CARE
Richmond, Virginia, United States, 23294
Sponsors and Collaborators
University of Virginia
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Investigators
Principal Investigator: Karen S Ingersoll, Ph.D. University of Virginia
  More Information

Publications:

Responsible Party: Karen Ingersoll, Associate Professor of Psychiatry and Neurobehavioral Sciences, University of Virginia
ClinicalTrials.gov Identifier: NCT01446653     History of Changes
Other Study ID Numbers: 12794
R01AA014356 ( U.S. NIH Grant/Contract )
First Submitted: October 2, 2011
First Posted: October 5, 2011
Last Update Posted: October 26, 2016
Last Verified: October 2016

Keywords provided by Karen Ingersoll, University of Virginia:
Fetal Alcohol Spectrum Disorders
FASDs
AEP risk
binge drinking
ineffective contraception

Additional relevant MeSH terms:
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs